BriaCell Therapeutics Corp. (BCTX): Shareholders' Equity
$15.56M
As of 2026-07-31
-10.9%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $15.56M | -10.2% | 2026-10-28, Balance as of period end |
| 2025-07-31 | $17.33M | n/m | 2026-10-28, Balance as of period end |
| 2024-07-31 | -$2.68M | n/m | 2025-10-16, Balance as of period end |
| 2023-07-31 | -$3.78M | n/m | 2024-10-29, Balance as of period end |
| 2022-07-31 | $10.33M | -62.7% | 2023-10-25, Balance as of period end |
| 2021-07-31 | $27.67M | n/a | 2022-10-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2026-07-31 | $15.56M | -10.2% |
| Immunic, Inc. (IMUX) | 2025-12-31 | -$6.67M | n/m |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $16.92M | -68.9% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $16.13M | -37.4% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $18.59M | -51.6% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $18.56M | +152.9% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $2.76M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.76M | +84.5% |
Compare BCTX, IMUX, RNTX, KPRX side by side · Screen every company in Pharmaceutical Preparations ↗